Moderna said early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa https://t.co/iuihDUx8oC

— Reuters (@Reuters) May 6, 2021